NCT06815224

Brief Summary

1 detect the relationship between perirenal fat thickness (PrFT) and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes (T2DM). 2)Explored the relationship between PRF thickness and the onset and progression of albuminuria in patients with diabetes 3)Evaluate associations between obesity-related markers with albuminuria and advanced kidney disease in patients with type 2 diabetes mellitus (DM)

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Mar 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

May 26, 2024

Completed
9 months until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

May 26, 2024

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • the thickness of preirenal fat in diabetic patients

    Follow up the patient with sonar to detect early changes in perirenal fat in diabetic patient. perirenal fat is the thickness of the fat capsule along the long axis of the kidney, and pararenal fat was the thickness of the fat layer measured between the medial surface of abdominal muscle tissue and the renal fascia.

    Basaline

Interventions

SonarDEVICE

Abdominal sonar

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Follow up patient is T2DM

You may qualify if:

  • \- Patients with T2DM aged 18-70 were included in this study. T2DM was diagnosed according to American Diabetes Association (ADA) ,Data collection will obtained over one year from October 2024 to October 2025.
  • Clinical diagnosis of Alzheimer's Disease Must be able to swallow tablets

You may not qualify if:

  • patients with a history of malignancy and surgical trauma.
  • patients diagnosed with nondiabetic renal diseases
  • Patients with renal replacement therapy (renal transplant or dialysis patients), renal morphological abnormalities (difference in kidney length between the two cm, solitary kidney or multiple kidneys, congenital kidney abnormalities, polycystic kidney, and hydronephrosis), liver cirrhosis.
  • Insulin dependent diabetes
  • Thyroid disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Marina Sobhy Masoud, Resident of Nephrology

CONTACT

Salma Mokhtar Osama, lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nephrology Resident

Study Record Dates

First Submitted

May 26, 2024

First Posted

February 7, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share